Major Shareholder Access Industries Buys $12.5M in Zura Bio Offering, Boosting Stake to 18.2%

summarizeSummary

Access Industries, a significant existing shareholder, purchased 2 million shares for $12.5 million in Zura Bio's recent public offering, increasing its beneficial ownership to 18.2%.

check_boxKey Events · Ownership and Investor Activity · ZURA

• Significant Share Purchase

  AI Biotechnology LLC, an entity controlled by Access Industries and Len Blavatnik, purchased 2,000,000 Class A Ordinary Shares.

• Substantial Investment Value

  The purchase was valued at $12.5 million, with shares acquired at $6.25 each, which was below the current market price of $6.89.

• Participation in Public Offering

  This investment was made as part of Zura Bio's recent registered public offering, which finalized on February 26, 2026, as previously reported in an 8-K filing.

• Increased Ownership Stake

  The reporting persons' beneficial ownership in Zura Bio Ltd. now stands at 18.2% of the outstanding Class A Ordinary Shares.

auto_awesomeAnalysis · ZURA · Life Sciences

This Schedule 13D/A filing reveals that AI Biotechnology LLC, an entity controlled by Access Industries and Len Blavatnik, made a substantial investment of $12.5 million in Zura Bio's recent public offering. This purchase of 2 million shares at $6.25 per share, which occurred on February 26, 2026, demonstrates strong conviction from a major existing investor. Their participation in the offering, which was dilutive for other shareholders, signals continued support for the company's strategy and financial health. The acquisition increases their beneficial ownership to 18.2% of the company, including shares issuable from warrants, reinforcing their long-term commitment. This move comes shortly after Zura Bio finalized its public offering, providing a positive signal amidst the capital raise.